About Sensible Biotechnologies
Sensible Biotechnologies is a company based in Wilmington (United States) founded in 2021 by Miroslav Gasparek.. Sensible Biotechnologies has raised $4.33 million across 2 funding rounds from investors including BlueYard Capital, Y Combinator and Amino Collective. Sensible Biotechnologies offers products and services including mRNA Manufacturing Platform and In Vivo Microbial mRNA System. Sensible Biotechnologies operates in a competitive market with competitors including Twist Bioscience, Parse Biosciences, Ansa Biotechnologies, Sino Biological and GenScript, among others.
- Headquarter Wilmington, United States
- Founders Miroslav Gasparek
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sensible Biotechnologies, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.33 M (USD)
in 2 rounds
-
Latest Funding Round
$4.2 M (USD), Seed
Feb 21, 2023
-
Investors
BlueYard Capital
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sensible Biotechnologies
Sensible Biotechnologies offers a comprehensive portfolio of products and services, including mRNA Manufacturing Platform and In Vivo Microbial mRNA System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Produces pure mRNA for therapeutics and vaccines efficiently.
Enables scalable mRNA production for global health applications.
Funding Insights of Sensible Biotechnologies
Sensible Biotechnologies has successfully raised a total of $4.33M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $4.2 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $4.2M
-
First Round
First Round
(01 Jun 2021)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2023 | Amount | Seed - Sensible Biotechnologies | Valuation | BlueYard | |
| Jun, 2021 | Amount | Seed - Sensible Biotechnologies | Valuation | Y Combinator |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sensible Biotechnologies
Sensible Biotechnologies has secured backing from 8 investors, including venture fund and angel investors. Prominent investors backing the company include BlueYard Capital, Y Combinator and Amino Collective. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
BlueYard Capital is engaged in early-stage technology investments.
|
Founded Year | Domain | Location | |
|
Early-stage startups are accelerated via funding and educational programs.
|
Founded Year | Domain | Location | |
|
Amino Collective is engaged in backing innovative startup founders.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sensible Biotechnologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sensible Biotechnologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sensible Biotechnologies Comparisons
Competitors of Sensible Biotechnologies
Sensible Biotechnologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Twist Bioscience, Parse Biosciences, Ansa Biotechnologies, Sino Biological and GenScript, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Synthetic DNA is synthesized via a semiconductor-based platform.
|
|
| domain | founded_year | HQ Location |
RNA-sequencing transcriptome kits for health data analysis are developed.
|
|
| domain | founded_year | HQ Location |
DNA synthesis technology using enzymes is provided.
|
|
| domain | founded_year | HQ Location |
Reagents and kits are provided for clinical research applications.
|
|
| domain | founded_year | HQ Location |
Reagents and instruments are provided for life sciences research.
|
|
| domain | founded_year | HQ Location |
Develops tools and products for research and clinical application
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sensible Biotechnologies
Frequently Asked Questions about Sensible Biotechnologies
When was Sensible Biotechnologies founded?
Sensible Biotechnologies was founded in 2021.
Where is Sensible Biotechnologies located?
Sensible Biotechnologies is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.
Who is the current CEO of Sensible Biotechnologies?
Miroslav Gasparek is the current CEO of Sensible Biotechnologies. They have also founded this company.
Is Sensible Biotechnologies a funded company?
Sensible Biotechnologies is a funded company, having raised a total of $4.33M across 2 funding rounds to date. The company's 1st funding round was a Seed of $125K, raised on Jun 01, 2021.
What does Sensible Biotechnologies do?
Sensible Biotechnologies was founded in 2021 and is headquartered in Wilmington, United States. Focus is placed on the biotechnology sector, where mRNA technology is designed and manufactured for therapeutics and vaccines. Principles of cell engineering, computational biology, and precision fermentation are integrated into operations to enable efficient production. Leadership is provided by co-founder and CEO Miroslav Gasparek, with activities centered on advancing mRNA applications in healthcare.
Who are the top competitors of Sensible Biotechnologies?
Sensible Biotechnologies's top competitors include Sino Biological, Parse Biosciences and GenScript.
What products or services does Sensible Biotechnologies offer?
Sensible Biotechnologies offers mRNA Manufacturing Platform and In Vivo Microbial mRNA System.
Who are Sensible Biotechnologies's investors?
Sensible Biotechnologies has 8 investors. Key investors include BlueYard Capital, Y Combinator, Amino Collective, Civilization Ventures, and Recode Ventures.